Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells

Cancer Research

Volumn 58, Issue 12, 1998, Pages 2667-2674

  Niinaka, Yasufumi ^a   Paku, Sandor ^a   Haga, Arayo ^a   Watanabe, Hideomi ^b   Raz, Avraham ^a,c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b GUNMA UNIVERSITY   (Japan)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCRINE MOTILITY FACTOR; GLUCOSE 6 PHOSPHATE ISOMERASE; NEUROLEUKIN;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; AUTOCRINE MOTILITY FACTOR; BASE SEQUENCE; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; MATURATION-PROMOTING FACTOR; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEUROLEUKIN; TUMOR CELLS, CULTURED;

EID: 0032525859     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Liotta, L. A., Rao, C. N., and Barsky, H. Tumor invasion and the extracellular matrix. Lab. Invest., 49: 636-649, 1983.
2. Nabi, I. R., Watanabe, H., and Raz, A. Autocrine motility factor and its receptor: role in cell locomotion and metastasis. Cancer Metastasis Rev., 11: 5-20, 1992.
3. Stoker, M., and Gherardi, E. Regulation of cell movement: the motility cytokines. Biochim. Biophys. Acta, 1072: 81-102, 1991.
4. Liotta, L. A., Mandler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K., and Schiffmann, E. Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci. USA, 83: 3302-3306, 1986.
5. Nabi, I. R., Watanabe, H., and Raz, A. Identification of B16-F1 melanoma autocrine motilily-like factor receptor. Cancer Res., 50: 409-414, 1990.
6. Silletti, S., Watanabe, H., Hogan, V., Nabi, I. R., and Raz, A. Purification of B16-F1 melanoma autocrine motility factor and its receptor. Cancer Res., 51: 3507-3511, 1991.
7. Watanabe, H., Carmi, P., Hogan, V., Raz, T., Silletti, S., Nabi, I. R., and Raz, A. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J. Biol. Chem., 266: 13442-13448, 1991.
8. Watanabe, H., Nabi, I. R., and Raz, A. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells. Cancer Res., 51: 2699-2705, 1991.
9. Kohn, E. C., Liotta, L. A., and Shiffman, E. Autocrine motility factor stimulates a three-fold increase in inositol phosphate in human melanoma cells. Biochem. Biophys. Res. Commun., 166: 757-764, 1990.
10. Silletti, S., Timer, J., Honn, K. V., and Raz, A. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high-and low-metastatic K1735 melanoma cell variants. Cancer Res., 54: 5752-5756, 1994.
11. Timar, J., Silletti, S., Bazaz, R., and Honn, K. V. Regulation of melanoma cell motility by the lipoxygenase metabolite 12(S)-HETE. Int. J. Cancer, 55: 1003-1010, 1993.
12. Watanabe, H., Takehama, K., Date, M., Shinozaki, T., and Raz, A. Tumor cell motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res., 56: 2960-2963, 1996.
13. Gurney, M. E., Heinrich, S. P., Lee, M. R., and Yin, H-S. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science (Washington DC). 234: 566-574, 1986.
14. Gurney, M. E., Apatoff, B. R., Spear, G. T., Baumel, M. J., Antel, J. P., Bania, M. B., and Reder, A. T. Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science (Washington DC), 234: 574-581, 1986.
15. Chaput, M., Claes, V., Portetelle, D., Cludts, I., Cravador, A., Burny, A., Gras, H., and Tartar, A. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (Lond.), 332: 454-455, 1988.
16. Baumann, M., and Brand, K. Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin. Cancer Res., 48: 7018-7021, 1988.
17. Baumann, M., Kappel, A., Brand, K., Siegfield, W., and Paterok, E. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. Cancer Invest., 8: 351-356, 1990.
18. Filella, X., Molina, R., Jo, J., Mas, E., and Ballesta, A. M. Serum phosphohexose isomerase activities in patients with colorectal cancer. Tumor Biol., 12: 360-367, 1991.
19. Patel, P. S., Rawal, G. N, Rawal, R. M., Patel, G. H., Balar, D. B., Shah. P. M., and Patel, D. C. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer. Neoplasia, 42: 271-274, 1995.
20. Bodansky, O. Serum phosphohexose isomerase in cancer. II. As an index of tumor growth in metastatic carcinoma of the breast. Cancer (Phila.), 7: 1200-1226, 1954.
21. Shwarz, M. K. Laboratory aids to diagnosis: enzymes. Cancer (Phila.), 17: 542-548, 1976.
22. Xu, W., Seiter. K., Feldman, E., Ahmed, T., and Chiao, J. W. The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood, 87: 4502-4506, 1996.
23. Rubartelli, A., Cozzolino, F., Talio, M., and Sitia, R. A novel secretory pathway for interleukin-1B, a protein lacking a signal sequence. EMBO J., 9: 1503-1510, 1990.
24. Ebert, D. L., Jordan, K. B., and Dimond, R. L. Lysosomal enzyme secretory mutants of Dictyostelium discoideum. J. Cell Sci., 96: 491-500, 1990.
25. Schwarzbauer, J. E., Spencer, C. S., and Wilson, C. L. Selective secretion of alternatively spliced fibronectin variants. J. Cell Biol., 109: 3445-3453, 1989.
26. Delli-Bovi, P., Curatola, A. M., Newman, K. M., Sato, Y., Moscatelli, D., Hewick, R. M., Rifkin, D. B., and Basilico, C. Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol. Cell. Biol., 8: 2933-2941, 1988.
27. Dorner, A. J., Wasley, L. C., Raney, P., Haugejorden, S., Green, M., and Kaufman, R. J. The stress response in Chinese hamster ovary cells. Regulation of ERp72 and protein disulfide isomerase expression and secretion. J. Biol. Chem., 265: 22029-22034, 1990.
28. Sloan, I. S., Horowitz, P. M., and Chirgwin, J. M. Rapid secretion by a nonclassical pathway of overexpressed mammalian mitochondrial rhodanese. J. Biol. Chem., 269: 27625-27630, 1994.
29. Watanabe, H., Kanbe, K., and Chigira, M. Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma. Clin. Exp. Metastasis, 12: 155-165, 1994.
30. Zvibel, I., and Raz, A. The establishment and characterization of a new Balb/c angiosarcoma tumor system. Int. J. Cancer, 36: 261-272, 1985.
31. Niinaka, Y., Oida, S., Ishisaki, A., Takeda, K., Iimura, T., Maruoka, Y., Momose, F., Negishi, A., Ichijo, H., Amagasa, T., Sasaki, S., Watanabe, H., and Raz, A. Autocrine motility factor and its receptor expressions in oral squamous cell carcinoma (SCC) cells. Int. J. Oncol., 9: 433-438, 1996.
32. Lee, J., Ishihara, A., Theriot, J. A., and Jacobson, K. Principles of locomotion for simple-shaped cells. Nature (Lond.), 362: 167-171, 1993.
33. Benlimame, N., Simard, D., and Nabi, I. R. Autocrine motility factor receptor is a marker for a distinct membranous organelle. J. Cell Biol., 129: 459-471, 1995.
34. Doyle, G. E., Sharief, Y., and Mohler, J. L. Prediction of metastatic potential by cancer cell motility in the dunning R-3327 prostatic adenocarcinoma in vitro model. J. Urol., 147: 514-518, 1992.
35. Otto, T., Birchmeier, W., Schmidt, U., Hinke, A., Schipper, J., Rübben, H., and Raz, A. Inverse relation of E-cadherin and autocrine motility factor receptor expression as prognostic factor in patients with bladder carcinoma. Cancer Res., 54: 3120-3123, 1994.
36. Nakamori, S., Watanabe, H., Kameyama, M., Iaoka, S., Furukawa, H., Ishikawa, O., Sasaki, Y., Kabuto, T., and Raz, A. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer (Phila.), 74: 1855-1862, 1994.
37. Maruyama, K., Watanabe, H., Hitoshi, S., Takayama, T., Gofuku, J., Yano, H., Inoue, M., Tamura, S., Raz, A., and Monden, M. Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma. Int. J. Cancer, 64: 316-321, 1995.
38. Nagai, Y., Ishikawa, O., Miyachi, Y., and Watanabe, H. Expression of autocrine motility factor receptor in cutaneous malignant. Dermatology, 192: 8-11, 1996.
39. Hirono, Y., Fushida, S., Yonemura, Y., Yamamoto, H., Watanabe, H., and Raz, A. Expression of autocrine motility factor correlates with disease progression in human gastric cancer. Br. J. Cancer, 74: 2003-2007, 1996.
40. Lee, M. R., Ho, D. D., and Gurney, M. E. Functional and partial homology between human immunodeficiency virus and neuroleukin. Science (Washington DC), 237: 1047-1051, 1987.
41. McNeil, R. K., Muthukrishnan, L., Warder, E., and D'Amore, P. A. Growth factors are released by mechanically wounded cells. J. Cell Biol., 109: 811-822, 1989.
42. Suttles, J., Giri, J. G., and Mizel, S. B. IL-1 secretion by macrophages. Enhancement of IL-1 secretion and processing by calcium ionophores. J. Immunol., 144: 175-182, 1990.
43. Mignatti, P., Morimoto, T., and Rifkin, D. B. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell. Physiol., 151: 81-93, 1992.
44. Cooper, D. N. W., and Barondes, S. H. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J. Cell Biol., 110: 1681-1691, 1990.
45. Sato, S., Burdett, I., Hughes, R. C. Secretion of the baby hamster kidney 30-kDa galactose-binding lectin from polarized and nonpolarized cells: a pathway independent of the endoplasmic reticulum-Golgi complex. Exp. Cell Res., 207: 8-18, 1993.
46. Lindstedt, R., Apodaca, G., Barondes, S. H., Mostov, K. E., and Leffler, H. Apical secretion of a cytosolic protein by madin-darby canine kidney cells. J. Biol. Chem., 268: 11750-11757, 1993.
47. Shin, J. T., Opalenik, S. R., Wehby, J. N., Mahesh, V. K., Jackson, A., Tarantini, F., Maciag, T., and Thompson, J. A. Serum-starvation induced the extracellular appearance of FGF-1. Biochim. Biophys. Acta, 1312: 27-38, 1996.
48. Siders, W. M., and Mizel, S. B. Interleulin-1β secretion. J. Biol. Chem., 270: 16258-16264, 1996.
49. Murata, J., Lee, H. Y., Clair, T., Krutzsch, H. C., Arestad, A. A., Sobel, M. E., Liotta, L. A., and Stracke, M. L. cDNA cloning of human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterase. J. Biol. Chem., 269: 30479-30484, 1994.
50. Yoshimura, A., Kuwazuru, Y., Furukawa, T., Yoshida, H., Yamada, K., and Akiyama, S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim. Biophys. Acta, 1034: 107-113, 1990.
51. Hoogewerf, A. J., Leone, J. W., Reardon, I. M., Howe, W. J., Asa, D., Heinrikson, R. L., and Ledbetter, S. R. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. Am. Soc. Biochem. Mol. Biol., 270: 3268-3277, 1995.
52. Paul, D., Niewiarowski, S., Varma, K. G., Rucinski, B., Rucker, S., and Lange, E. Human platelet basic protein associated with antiheparin and mitogenic activities: purification and partial characterization. Proc. Natl. Acad. Sci. USA, 44: 5914-5918, 1980.